KRYS Stock Signals: 7 Detections Since 2018
JumpstartSignal's 5-stage screening system flagged Krystal Biotech (KRYS) on 7 individual trading days (3 signal clusters) across our 14-year backtest (2012–2025). Best signal: +1296% from Oct 15, 2018 vs +180% SPY over the same period.
(vs +179% SPY)
3/3 clusters
3 clusters
per signal
About Krystal Biotech
Krystal Biotech develops redosable gene therapy products delivered via a proprietary non-integrating HSV-1 vector platform. Its first commercial product, VYJUVEK (beremagene geperpavec), treats dystrophic epidermolysis bullosa — a severe rare skin disease — and its 2023 approval and rapid commercial uptake validated both the disease area and the novel redosable gene therapy approach.
KRYS Signal History (2018–2023)
Each row represents one signal cluster — when consecutive daily signals appeared they are grouped together. Entry price shown is the best entry within each cluster. Returns measured to 2026-02-01.
| Signal Date | Entry Price | Return | Price (Feb '26) | SPY (same period) | Alpha |
|---|---|---|---|---|---|
| Oct 15, 2018 2-day | $20.00 | +1296% | $279.24 | +180% | +1117% |
| Apr 13, 2023 4-day | $86.38 | +223% | $279.27 | +72% | +151% |
| May 9, 2023 | $91.82 | +204% | $279.22 | +73% | +131% |
KRYS Return vs SPY — per signal cluster
Past performance does not indicate future results. Returns calculated from each signal's entry date to 2026-02-01. Consecutive daily signals within 14 days are grouped as one cluster; best entry price within the cluster is shown. Data sourced from JumpstartSignal's 14-year backtest using historical prices.
How JumpstartSignal Screened KRYS
Each KRYS signal above passed through all five stages:
Stage 3 scores quality signals — ROE, low debt, MA stack (0–60 pts) — and entry timing signals — golden cross, breakout volume, VWAP momentum (0–20 pts). Stage 4 adds AI news sentiment (0–10 pts) and a sector bonus (0–10 pts) for a combined score out of 100. KRYS reached ✅ OPPORTUNITY status (score ≥70) — appearing in the daily watchlist alongside 🏆 SPOTLIGHT (≥73) signals.
Full methodology →Get signals like these delivered daily
When stocks pass all 5 stages of our screening system, the signal lands in your inbox each trading day.
No spam. Unsubscribe in one click.